Pharming Group N.V. (PHAR) Current Leases (2019 - 2024)
Pharming (PHAR) has disclosed Current Leases for 6 consecutive years, with $2.9 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Current Leases fell 18.53% year-over-year to $2.9 million, compared with a TTM value of $2.9 million through Dec 2024, down 18.53%, and an annual FY2024 reading of $2.9 million, down 18.53% over the prior year.
- Current Leases was $2.9 million for Q4 2024 at Pharming, down from $3.6 million in the prior quarter.
- Across five years, Current Leases topped out at $3.6 million in Q4 2023 and bottomed at $1.9 million in Q4 2020.
- Average Current Leases over 5 years is $2.9 million, with a median of $2.9 million recorded in 2024.
- The sharpest move saw Current Leases surged 43.24% in 2022, then decreased 18.53% in 2024.
- Year by year, Current Leases stood at $1.9 million in 2020, then grew by 26.96% to $2.4 million in 2021, then soared by 43.24% to $3.5 million in 2022, then grew by 4.36% to $3.6 million in 2023, then dropped by 18.53% to $2.9 million in 2024.
- Business Quant data shows Current Leases for PHAR at $2.9 million in Q4 2024, $3.6 million in Q4 2023, and $3.5 million in Q4 2022.